BRIEF published on 03/20/2026 at 15:49, 6 months 5 days ago Guerbet: Publication of the 2025 Universal Registration Document Financial Report Guerbet Medical Imaging Financial Markets Registration Document
BRIEF published on 03/20/2026 at 15:49, 6 months 5 days ago Guerbet : Publication du Document d'enregistrement universel 2025 Rapport Financier Guerbet Imagerie Médicale Marchés Financiers Document D'enregistrement
PRESS RELEASE published on 03/20/2026 at 15:44, 6 months 5 days ago GUERBET : Mise à disposition du Document d’enregistrement universel 2025 Guerbet dépose son Document d’enregistrement universel 2025 à l'AMF. Consultation gratuite en ligne. Prochain RDV : Publication du chiffre d’affaires du 1er trimestre 2026 le 23 avril 2026 Chiffre D’affaires AMF Guerbet Publication Document D’Enregistrement Universel 2025
BRIEF published on 02/20/2026 at 17:50, 7 months 4 days ago Guerbet: Capital update as of January 31, 2026 Voting Rights Capital Actions Guerbet 2026
BRIEF published on 02/20/2026 at 17:50, 7 months 4 days ago Guerbet : Mise à jour sur le capital au 31 janvier 2026 Capital Droits De Vote Actions Guerbet 2026
PRESS RELEASE published on 02/20/2026 at 17:45, 7 months 4 days ago GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 janvier 2026 Déclaration du nombre de droits de vote et d'actions composant le capital d'une société, conformément à la réglementation en vigueur Droits De Vote Code De Commerce Actions AMF Société
BRIEF published on 01/27/2026 at 18:10, 7 months 28 days ago Approbation européenne pour l'utilisation d'Elucirem™ de Guerbet chez l'enfant dès la naissance Guerbet Commission Européenne Elucirem™ Imagerie Pédiatrique Contraste À Base De Gadolinium
BRIEF published on 01/27/2026 at 18:10, 7 months 28 days ago European Approval for Guerbet's Elucirem™ Use in Children from Birth European Commission Guerbet Elucirem™ Pediatric Imaging Gadolinium-Based Contrast
PRESS RELEASE published on 01/27/2026 at 18:05, 7 months 28 days ago New indication in children from birth for Guerbet's half-dose GBCA, Elucirem™ (Gadopiclenol) approved by European Commission Guerbet's Elucirem (Gadopiclenol) receives European Commission approval for new indication in children from birth, with half-dose GBCA for MRI imaging European Commission Guerbet MRI Imaging Elucirem Gadopiclenol
BRIEF published on 12/19/2025 at 08:50, 9 months 6 days ago Guerbet nomme François Convenant à un poste de direction clé Comité Exécutif Guerbet Innovation Dans Le Secteur De La Santé François Convenant Radiologie Interventionnelle
Published on 09/25/2026 at 15:00, 1 hour ago HM Exploration Provides Program Update for the Lewis Pilley's Project
Published on 09/25/2026 at 14:00, 2 hours ago Karbon-X (OTCQB:KARX) to Present Global Growth Strategy and Showcase SkyXero at 26th MK-Equity Investment Conference in Munich
Published on 09/25/2026 at 13:00, 3 hours ago American Hotel Income Properties REIT LP Announces Corporate Update
Published on 09/25/2026 at 13:00, 3 hours ago UraniumX Plans Winter Gravity Program at Murphy Lake as Q4 Assays Approach
Published on 09/25/2026 at 15:50, 10 minutes ago Zentra Group plc: One Victoria – Replacement Building Contract Signed
Published on 09/25/2026 at 15:37, 23 minutes ago EQS-Adhoc: RAG-Stiftung: RAG-Stiftung regarding a potential takeover of Evonik by BASF
Published on 09/25/2026 at 15:30, 30 minutes ago Les dirigeants africains appellent à renforcer le financement national et l'action multisectorielle pour accélérer l'élimination du paludisme
Published on 09/25/2026 at 15:30, 30 minutes ago African leaders call for stronger domestic financing and multisectoral action to accelerate malaria elimination
Published on 09/25/2026 at 15:12, 48 minutes ago EQS-Adhoc: Evonik Industries AG confirms receipt of a non-binding approach from BASF SE regarding a potential takeover offer
Published on 09/25/2026 at 07:00, 8 hours 59 minutes ago ENGIE mobilise une aide exceptionnelle de 54 millions d'euros pour soutenir les ménages les plus fragiles face à la hausse des prix de l'énergie
Published on 09/24/2026 at 18:31, 21 hours 28 minutes ago LNA SANTE : Mise à disposition du rapport financier semestriel 2026
Published on 09/24/2026 at 18:00, 22 hours ago GUILLEMOT CORPORATION: Availability of the interim financial report to June 30, 2026
Published on 09/24/2026 at 18:00, 22 hours ago GUILLEMOT CORPORATION : Mise à disposition du rapport financier semestriel au 30 juin 2026
